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From the 
President 
"In this country doctors are, 
as a rule, bad citizens, taking 
little or no interest in civic, state or national politics. Let me ... tell 
of one of us ... who ... has found time to serve his city and his country. 
For more than twenty years Virchow has sat in the Berlin City 
Council as an alderman, and to no feature in his extraordinary life 
does the Berliner point with more justifiable pride. It is a 
combination of qualities only too rare, when the learned professor 
can leave his laboratory and take his share in practical, municipal 
work." Wt'lliam Osler,189J' 
Colleagues: 
The days of summer are fleeting, and September is now upon 
us. With that in mind, I wanted to take this opportunity to tell 
you about the big plans for the September 11 General Medical 
Staff meeting. As I've been telling you for the past few 
months, we are planning to demonstrate the PHAMIS 4. N 
Patient Management System with computerized order entry. 
Representatives from LVH Information Services (1/S) and I will 
present a demonstration version of the new system. Over the 
past couple of weeks, I've been working with members of the 
1/S staff to begin the process of developing our physician order 
entry system so that it will be "user friendly" and will help us to 
make our hospital rounds more efficient. 
In August, the Medical Executive Committee viewed the first 
demonstration of the new computerized order entry system, 
which is planned for introduction in early summer 2001. 
Members of the committee had a number of comments and 
suggestions about the demonstration version of the system. 
Overall, I felt the first demonstration of this new software 
package was a success. However, much needs to be done 
before the rollout next year. We all need to be prepared to 
help in tailoring the system for our own use. 
As well, on September 11, from 7 a.m. to 9 p.m., 
representatives from 1/S will be in the Presidents' Room with 
multiple computer terminals set up so that members of the 
Medical Staff can sit down and take time to have a "hands on" 
demonstration of the system. These terminals will also be 
available after the Medical Staff meeting for your use. Please 
remember that the demonstration system we will be seeing on 
the 11th of September is not the final version that will be 
implemented at LVH. The newest version of this software is 
being upgraded and will be available in October, 2000. 
1 
Osier, William. Rudolph Virchow: the man and the student. Boston 
Med Surg J. 1891; 125:425-7 [Reprinted in McGovern JP, Roland 
CG (eds). The Collected Essays of Sir William Osier, vol. III. 
Birmingham, AL: Classics of Medicine Library; 1985, pp. 426-7]. 
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The Physician Order Entry Committee, chaired by Dr. John 
Jaffe, will be meeting regularly to help with the rollout of the 
computer order entry system so that the members of our staff 
will find it workable and easy to use. Members of the LVPHO 
Information Services Committee will also help in the 
development and rollout of this new and revolutionary system. 
From my conversations with Mr. Harry Lukens, Sr. Vice 
President and CIO, and members of his 1/S staff, I can assure 
you that they want our input and are prepared to do everything 
possible to make the introduction of this new system as trouble 
free and "physician friendly" as possible. If your input and 
recommendations are solicited, please don't hesitate to offer 
your opinion. By getting as much participation and buy-in from 
the Medical Staff early on, we will be able to have a system 
which will work for all of us and will help us do a better job 
taking care of our patients. 
By now you are probably asking yourself what benefits will I, 
as a physician, reap from the use of a computerized physician 
order entry system? Below, I have listed just a few. 
• Maximizes the efficiency of care 
• Reduces delay and errors from transcription 
• Permits remote ordering 
• Corrects illegible and incorrect orders 
• Allows interface of orders to scheduling 
• Allows interface of orders with managed care 
processes 
• Improves quality of care 
• Allows direct interface with physicians 
• Allows notice of drug interactions 
• Provides allergy checking 
• Reduces health care costs 
• Guides cost efficient choices 
• Supports clinical education 
• Provides online references 
• Provides online rules and references 
Once again, I ask for your patience, cooperation, and 
assistance as this installation and implementation progresses 
over the next nine months. We have much work to do. This 
will be "our" system. We can make it work the way we want it 
to. I believe in the benefits of this new system. I hope you will 
begin to share my enthusiasm for this revolutionary system 
that is being implemented primarily to reduce errors and to 
improve the quality of care we deliver to our patients. 
Legibility of our medical records continues to be a problem. I'll 
remind you again of the action taken at the June Medical 
Executive Committee meeting. The committee adopted a 
resolution to "require that signatures must be followed ~ 
the physician's printed name whenever H appears in the 
chart. A signature stamp will be provided by the hospital to 
physicians who feel that printing their name is too 
burdensome." The Medical Record Department will consider 
charts, in which signatures are illegible, incomplete, and 
appropriate action, as specified in the Medical Staff Bylaws, 
will be enforced. 
In my last month's Medical Staff Progress Notes article, I 
made some remarks about the rising cost of pharmaceuticals 
that we prescribe for our patients. I've heard a number of 
comments about these remarks. At our Medical Executive 
Committee meeting in August, we had a brief discussion about 
the topic, and I plan to bring this subject up again for 
discussion at the September meeting of the Medical Executive 
Committee. 
It is not uncommon or unheard of for many of my Medicare 
patients with several chronic illnesses to have to spend 
upwards of $4,000/year for medications that I have prescribed 
for them to deal with their various illnesses. These 
medications can be remarkably effective in helping them deal 
with their chronic conditions. They may also reduce the 
number of hospitalizations that are required to take care of 
these patients. With these medications, patients may live 
more functional and productive lives. I am all in favor of the 
development and marketing of new and effective medications 
which are proven in large controlled studies to help reduce 
morbidity, prolong life, reduce hospitalization, and improve the 
quality of life. I recognize that the development of these new 
medications cost a great deal of money for the pharmaceutical 
industry, which invests in research and development required 
in producing these new products. I also believe that monetary 
incentives are necessary to stimulate this research which, on 
many occasions, is not rewarded with the success of 
marketing a new drug. 
I am very concerned, however, with several aspects of the 
current pharmaceutical industry's approach to drug 
development and marketing. The first of these is the 
development of "look alike" drugs. Do we really need 15 to 20 
ACE inhibitors for the treatment of hypertension, CHF, and 
diabetic renal disease? Do we really need four "proton pump" 
inhibitors at $3.00/capsule for the treatment of acid reflux 
disease? These are just examples of the tendency for 
competing drug companies to develop similar drugs with minor 
chemical modifications so that they can reduce their R&D 
costs and then devote huge marketing budgets to promote 
these medications to physicians and now directly to the public. 
(Continued on Page 3) 
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All of the drug companies want to get on the "gravy train" so 
they can share in the windfall profits that are now available in 
this uncontrolled mari<etplace. 
Why do most of these "look alike" drugs cost almost the same 
amount for a one-month supply? Each company knows that 
the mari<-up on their drugs is so high that by competing on 
price they would soon be involved in a price war and they 
would all lose. With the advent of drug prescription plans that 
pay for medications, the pharmaceutical industry is unfettered 
in its propensity to continually increase the cost of drugs to our 
patients and to those who pay for the drugs. We, the 
physicians, are the consumers, but we do not bear any of the 
responsibility for having to pay for medications that we 
prescribe for our patients. Our patients are placed in the 
position of having to pay for medications which they have no 
choice in selecting. They can't decide whether they want to 
buy the BMW or the Yugo when it comes to prescription 
medications. The usual mari<et forces that drive consumer 
choices do not apply to prescription drugs that are prescribed 
by physicians and taken by patients. 
Would you want your physician recommending a drug for your 
use because he has been given tickets to the U.S. Senior 
Open at Saucon Valley Country Club, the Philadelphia Phillies, 
or the Philadelphia Eagles? I don't believe that I should 
choose a medication for my patient because I was given $40 
worth of Chinese food at Wegman's at a "dine & dash," or free 
ice cream at Ice Cream World, or bagels at Chesapeake Bagel 
Company on Tuesday and Thursday mornings every month? 
Ask yourself, "Why are the majority of the drug representatives 
very attractive young women {or handsome young men)?" I 
believe that my colleagues and I should be receiving our drug 
information from appropriate, reputable, readily available peer 
reviewed sources in the medical literature, not from attractive 
salespersons who hand out pens, notepads, paperweights, 
coffee mugs, and the like. Just imagine what could happen to 
the mari<et price of prescription medications if the 
pharmaceutical companies reduced their mari<eting budgets by 
25- 50%, used this windfall to reinvest in R&D, and lowered 
the price of prescription medications. Wouldn't that be a 
revolutionary thought! What would happen if we depended on 
intelligent physicians to prescribe medications based on their 
knowledge about pharmaceuticals obtained from the peer 
reviewed medical literature? What might happen if all 
members of the LVH Medical Staff read The Medical Letter2 
every two weeks? 
Remember, we are not talking about antibiotics which are 
usually only used for a short time period. I am primarily 
concerned about medications that are prescribed for chronic 
2 http:/ /medletter.com 
conditions. Fortunately, many of us can afford to purchase 
these medications because of our success or good luck. Many 
Americans are not as fortunate. Wouldn't it be better for Merck 
to sell Zocortm for $0.20/tablet to the 10 million Americans who 
would benefit from its use than to sell it for $2.00/tablet to the 
one million who were fortunate enough to be able to afford it? 
Wouldn't it be great if people could afford to take their 
medications and buy groceries at the same time? 
I hope that I am not the only physician on this medical staff 
who is outraged by the continuing rise in prescription drug 
prices. I hope that other members of our staff are equally 
concerned by the exorbitant profits that the pharmaceutical 
industry reaps at the expense of our patients. Prescription 
drug costs rose by approximately 14% last year. It has been 
estimated that 18% of the nation's health care budget is 
related to physician charges. The same study estimates that 
prescription drug costs account for 20% of the nation's health 
care budget! I hope that the members of our Medical Staff will 
write to their senators and congressmen supporting federal 
legislation designed to place some control on prescription drug 
costs, and to control the huge expenditures that the drug 
companies spend on mari<eting to physicians and directly to 
the public. (We should all be cognizant of Osler's comments 
about Virchow and the value of physician involvement in a 
political cause.) 
Many of you remember my involvement in a project several 
years ago to try to improve our care for patients with 
congestive heart failure. This project included efforts to 
shorten inpatient length of stay, reduce the costs of inpatient 
care, improve the quality of outpatient care, and reduce the 
readmission rate for these patients. Dr. Keith Doram has 
been managing this project for over one year. I've recently 
received some data about the success of this program. From 
July, 1999 through May, 2000, the length of hospital stay for 
patients admitted with a diagnosis of CHF has fallen from 5.6 
days to 4.5 days. The average cost/case for patients 
hospitalized with CHF over the same period fell from $2,100 to 
slightly less than $1,800. This is real progress! I want to 
commend Dr. Doram and all of those involved in this project for 
their successful efforts. A great deal of the credit for this 
success is due to the efforts of all of the physicians who care 
for patients with congestive heart failure admitted to LVH and 
LVH-M. 
(Continued on Page 4) 
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I look forward to seeing you at the General Medical Staff 
meeting on Monday, September 11, at 6 p.m., in the 
Auditorium at Lehigh Valley Hospital, Cedar Crest & 1-78. We 
will be nominating and holding the election for the new 
President-elect of the LVH Medical Staff at this meeting. 
Please try to attend this important meeting. Also, please take 
some time to stop by the Presidents' Room between 7 a.m. to 
9 p.m., on September 11 for a hands-on session with the 
physician order entry software! 
tl~ 
David M. Caccese, MD 
Medical Staff President 
Physician Order Entry Is Coming ... 
Demo's with hands-on sessions will be 
available for members of the Medical Staff 
on Monday, September 11, from 7 a.m. to 9 
p.m., in the Presidents' Room at Lehigh 
Valley Hospital, Cedar Crest & I-78. 
Ambulation Protocol Approved 
At its June 6 meeting, the Medical Executive Committee 
approved an ambulation protocol that was designed to 
facilitate early and appropriate ambulation with patients. 
Education related to the protocol is currently underway, and 
implementation is scheduled for October, 2000. 
If you have any questions, please contact Kathleen Baker, 
Director of Physical and Occupational Therapy, at (610) 402-
8480. 
Cancer Staging at L VH-Muhlenberg 
In order to comply with the Commission on Cancer's program 
accreditation requirements, cancer staging is being 
implemented at LVH-M on September 1, 2000. Physicians 
with privileges at LVH-Muhlenberg will receive an individual 
mailing which contains a description of the staging process, a 
listing of the organ sites for which staging is required, and 
samples of several staging sheets. If you have any questions 
regarding this issue, please contact the Tumor Registry at 
(610) 402-0520. 
Interactive Safety Training 
According to the Joint Commission on the Accreditation of 
Healthcare Organizations (JCAHO), all members of the 
hospital's staff, including employees, volunteers, and 
physicians, must complete an annual mandatory safety training 
program. To accomplish this paramount task in a more 
efficient, user-friendly manner, the hospital has introduced a 
new computer-based interactive learning system. 
This system -- de'Medici -- has been installed on numerous PC 
workstations throughout LVHHN and encompasses all 
JCAHO/OSHA requirements such as fire safety, infection 
control, bloodborne pathogens, workplace violence, and 
emergency preparedness. 
The following areas are available for physicians to drop in to 
do their de' Medici training: 
Cedar Crest & 1-78 
Learning Resource Center 
Health Sciences Library 
17fh & Chew 
LVH-M 
Medical Staff Lounge 
Health Sciences Library 
Medical Staff Lounge 
Health Sciences Library 
As you may know, JCAHO inspection of Lehigh Valley Hospital 
is scheduled for later this year. Therefore, ALL members of 
the staff should complete their training before the end of 
October. 
If you have any questions regarding the de'Medici interactive 
safety training, please contact Suzanne Rice via e-mail or at 
484-884-2560. 
Medical Staff Dues 
On September 1, letters regarding annual Medical 
Staff dues will be distributed to members of the 
common Medical Staff of Lehigh Valley Hospital and 
Lehigh Valley Hospital-Muhlenberg. Payment of dues is 
requested on or before September 15, 2000. Timely 
remittance of dues is both requested and appreciated. 
If you have any questions regarding your Medical Staff 
dues, please contact Janet M. Seifert in Physician 
Relations at (610) 402-8590. 
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News from the HIM Department 
Document Imaging 
Dictation Record View 
Input from physicians has been requested for ways to improve 
the document imaging system. One of the concerns is the 
increased time it takes to do dictations after records are 
scanned into the imaging system. In an effort to improve the 
process, "Physician Dictation View" has been created. The 
dictation view eliminates all of the administrative documents 
from view. To utilize this view, scroll on the tool bar directly 
above the document lists until you get to the "Physician 
Dictation View" (views are in alphabetical order). Click on the 
"Physician Dictation View" and only the documents in this view 
will appear. If you need to view documents not contained in 
this view, you may, at any time, change to the "All Documents" 
view. 
Record Completion Process 
Wednesday, prior to current week, letters are mailed to 
medical staff listing all medical records with deficiencies. 
Thursday, prior to current week, resident staff receive letters 
for deficiencies. 
Monday of current week, a list is generated of all pending 
suspension charts, including any H&Ps and OPs which have 
not been completed. 
Tuesday of current week, a courtesy call is placed to all 
physicians who have deficiencies that are listed as "pending 
suspension" stating that these must be completed by 
Wednesday of the current week. 
Wednesday of current week, a suspension list is generated 
at 3 p.m. for deficiencies not completed by this time. 
Deficiency Assignment 
Deficiency assignments are made according to the guidelines 
that have been established by physician groups or individual 
physicians. The same guidelines that were in place prior to 
the document imaging system are being utilized, unless new 
instructions were provided to the HIM Department by the 
physicians. If changes need to be made to the assignment 
process, please contact the HIM Department. 
For ease in completing records, the document imaging system 
continues to be available on any "document imaging enabled" 
workstation on the units or in the HIM Department. The 
system enables the HIM Department staff to alert the 
physicians to chart deficiencies (histories and physicals) within 
24 hours after admission. Once the dictation has been 
transcribed, the deficiency is translated into a sign deficiency 
automatically. Since the system is updated on an ongoing 
basis, it is a good idea to sign in for chart completion 
frequently. 
Pending Suspension Deficiencies 
Remember, in the old paper world when physicians had to 
physically report to the HIM Department, the HIM staff knew 
when records were completed. With access conveniently 
available throughout the organization, even though the system 
is constantly checked, it is sometimes difficult to know that all 
suspension deficiencies have been completed. Please notify 
the HIM Department if you have completed "pending 
suspension" deficiencies outside the HIM Department at (61 0) 
402-8345. 
Persona/Identification Number 
If you forget your "signing PIN number," please call the liS 
Help Desk at (610) 402-8303. Staff is available Monday 
through Friday, 8 a.m. to 5 p.m. to assist you. Your PIN 
number is utilized for electronic signature/chart completion and 
does not interfere with your ability to access and review 
historical medical records. 
If you have any questions regarding Document Imaging, 
please contact Sue Cassium, Operations Coordinator, at (610) 
402-4451. 
Verbal/Telephone Orders 
Please remember to check your charts on rounds every day for 
yellow "sign-here" labels that indicate that there is a 
verbal/telephone order that needs a signature. 
For Your Calendar 
:Jo> A meeting of the General Medical Staff will be 
held on Monday, September 11, beginning at 6 
p.m., in the Auditorium at Lehigh Valley Hospital, 
Cedar Crest & I-78. An election of the next 
President-elect of the Medical Staff will be held 
at the meeting. All members of the Medical 
Staff are encouraged to attend. 
:Jo> The quarterly General Membership Meeting of 
the Greater Lehigh Valley Independent 
Practice Association will be held on Tuesday, 
September 26, at 6 p.m., in the Auditorium of 
Lehigh Valley Hospital, Cedar Crest & I-78. To 
receive credit for your attendance toward the 
Incentive Plan, please remember to sign in. 
:Jo> The next Physician Recognition Dinner will be 
held on Saturday, March 31, 2001, at the 
Holiday Inn Conference Center in fogelsville. 
Please mark your calendar! More information will 
follow as the date gets closer. 
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Patient Transport Service 
In an effort to decrease the amount of time that patients wait to 
go to testing or return from testing, members of Clinical 
Services and Materials Management have worked together to 
create a Patient Transport Service which will begin on 
September 5 at Cedar Crest & 1-78. 
Currently, patients are transported by Support Partners. 
Through a study completed by a workflow analysis group, it 
was found that Support Partners spend 60% of their time off 
the floors transporting patients. This results in decreased 
productivity on the units. 
With the new Patient Transport Service, transporters will be 
dispatched through a centralized location. This should 
decrease the amount of patient wait time and allow for 
increased productivity by Support Partners on the units. 
Hours for the Patient Transport Service will be 7 a.m. to 8 p.m., 
Monday through Friday, and 7:30 a.m. to 4 p.m., on weekends 
and holidays. The main telephone number for the Patient 
Transport Service is (610) 402-6777. 
If you have any questions regarding this service, please 
contact Will Mest, Supervisor, Mailroom/Printshop, at (610) 
402-5043. 
Upcoming Screening Programs 
Legs for Life Screening 
The early detection and treatment of vascular disease can 
mitigate more serious future health problems. Lehigh Valley 
Hospital-Muhlenberg will host Legs for Life, a free Peripheral 
Vascular Disease (PVD) screening program for the community, 
as part of a national screening week sponsored by the Society 
of Cardiovascular & lnterventional Radiology (SCVIR). SCVIR 
is the national professional society of interventional radiologists 
~ho t~at PVD and many other conditions using minimally 
1nvas1ve procedures that are often alternatives to surgery. 
Lehigh Valley Hospital-Muhlenberg will offer Legs for Life 
screenings in the following locations throughout the area: 
September 25 • 6 to 9 p.m. 
Health Center at Trexlertown 
Trexler Mall, Route 222, Trexlertown 
September 26 • 8 a.m. to Noon 
Lehigh Valley Hospital-Muhlenberg 
Outpatient Registration - Kolb Center 
2545 Schoenersville Road, Bethlehem 
September 27 • 6 to 9 p.m. 
Lehigh Valley Hospital 
Diagnostic Care Center- Jaindl Family Pavilion 
Cedar Crest & 1-78, Allentown 
September 28 & 29 • 10 a.m. to 2 p.m. 
Senior Horizons 
Agricultural Hall, Allentown Fairgrounds 
17th & Chew Streets, Allentown 
Pre-registration is requested for the program. Patients may 
call (610) 402-CARE to register. 
During the screening, participants will answer a brief 
questionnaire to assess their risk for PVD. Medical staff will 
determine the Ankle Brachial Index (ABI) for signs of 
circulatory problems. Participants with multiple risk factors and 
symptoms, and those with abnormal ABis, will be advised to 
visit their primary care physician. The results from your 
patient's participation in the program, along with the screening 
physician's recommendations, will be sent to you following the 
program completion. If identified, you can then guide your 
patients in an appropriate treatment program. 
National Depression Screening Day 
In observance of National Depression Screening Day on 
Thursday, October 5, the Department of Psychiatry will offer 
free screenings at the following locations: 
Lehigh Valley Hospital 
John & Dorothy Morgan Cancer Center 
1240 S. Cedar Crest Blvd. 
Classrooms 1 A & 1 B 
Allentown, Pa. 
3 to 5 p.m. 
Lehigh Valley Hospital-Muhlenberg 
Banko Family Community Center 
2545 Schoenersville Road 
Rooms 1 &2 
Bethlehem, Pa. 
4 to 7 p.m. 
Each session will begin promptly with an education lecture and 
slide presentation. Free, anonymous depression screenings 
will follow. 
Reservations are suggested, but not required. For more 
information or to make a reservation, please call (610) 402-
CARE. 
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Good Shepherd Specialty Hospital-
Allentown Highlights its Programs 
Medically stable but fragile patients often need extended 
clinical care. Patients needing this level of care may be too ill 
for discharge to an acute rehabilitation hospital, nursing facility 
or their homes. For such patients, the Good Shepherd 
Specialty Hospital-Allentown (GSSH-A) provides outstanding 
acute care tailored to the needs of the patient. Over the next 
few months, the three major programs --Pulmonary Ventilator, 
Complex Medical, and Transitional Rehabilitation --will be 
highlighted in Medical Staff Progress Notes. 
The Pulmonary Ventilator Program - Under the direction of an 
experienced critical care pulmonologist, GSSH-A provides an 
aggressive team approach to meeting the needs of the 
complex respiratory patient. Patients with tracheostomies, 
those on ventilators, and those requiring extensive help to 
maintain normal breathing without mechanical support are 
ideal candidates for this program. 
GSSH-A has 24-hour/day coverage by Registered Respiratory 
Therapists. All have at least five years of critical care 
experience at leading centers of excellence, including Lehigh 
Valley Hosptial and Thomas Jefferson University Hospital. 
Therapists are experienced in waveform analysis, drawing 
ABG's, use of the lnexsufflator, Intra-pulmonary Ventilator, 
BIPAP, and are current with the new respiratory technology to 
enhance patient weaning and comfort. 
Currently, GSSH-A uses 7200 Ventilators with waveforms, 
flowby, pressure support, pressure controlled ventilation 
mechanisms and many other functions to enhance weaning. 
In addition, transport ventilators are available for patients 
requiring mechanical ventilation to facilitate patient mobility 
and ease of transport for special studies or procedures as are 
walking ventilators for patients that are slow weans but can 
benefit from more aggressive physical, occupational and 
speech therapy. 
Team conferences, led by the attending physician and 
including all members of the care team (respiratory, physical, 
occupational, speech therapy, care management, pharmacy 
and nursing), are held to evaluate individual patient needs and 
develop treatment plans to maximize progress toward goals. 
On-going patient and family education, that is disease specific, 
is part of the individualized treatment plans to maximize 
personal independence. 
If you have any questions or would like further information 
regarding the PulmonaryNentilator Program, please contact a 
member of the administrative team listed below or Stephen C. 
Matchett, Director, PulmonaryNentilator Program, at (610) 
439-8856 or pager (61 0) 920-7225. 
~ Jane Dorval, MD, President, Medical Staff, (610) 776-
3340 or pager (610) 830-2793 
~ Beverly Snyder, RN, Assistant Administrator/Director of 
Nursing, (610) 402-8599 or pager (610) 830-7665 
~ Joseph Pitingolo, Administrator, (61 0) 402-8559 or pager 
(610) 830-4023 
~ Linda Dean, Administrative Consultant, (61 0) 402-8963 or 
pager (610) 830-3110 
~ Nancy Hardick, Medical Staff Affairs, (610) 402-8962 
Do You Currently Have a Cafeteria Account? 
If so, your account number will be changing within 
the next few weeks. For those physicians who 
currently have cafeteria accounts, barcode 
stickers were issued to you when the new 
cafeteria barcode system was implemented. 
However, in an effort to simplify the process, the 
new Photo ID badges have built-in barcodes on 
the back of the badge. These barcode numbers 
will be input into the cafeteria barcode system 
and will replace your existing account number. 
Your new barcode number will go into effect on 
Friday, September 29. 
For those physicians with existing cafeteria 
accounts, new ID badges have been ordered and 
are available in Medical Staff Services on the 
first floor (just up the hall from Medical Records 
and the Medical Staff Lounge). If you have not 
yet picked up your new ID badge, please stop in 
Medical Staff Services, 8 a.m. to 5 p.m., Monday 
through Friday. If you have any questions, please 
contact Janet M. Seifert in Physician Relations at 
(610) 402-8590. 
Congratulations! 
Jon E. Brndjar, DO, and David M. Stein, DO, Division of 
General Internal Medicine, were recently notified of their 
election into the Conclave of Fellows of the American College 
of Osteopathic Internists. They will be recognized and 
awarded their fellowship certificates at the A COl's annual 
convention to be held October 4-8 in Boston, Mass. 
Mark A. Gittleman, MD, Division of General Surgery, has 
been named an auditor for the Senologic International Society, 
which is an international society for the study of breast disease 
and breast cancer treatment. 
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2000 United Way Campaign 
Lehigh Valley Hospital and Health Network will kick off its 2000 
United Way Campaign on September 21, 2000. This year, 
LVHHN's goal is a gift of $230,000 to the community! Last 
year, with the help of hundreds of LVHHN physicians and staff, 
nearly $220,000 was raised to support more than 115 health 
and human services programs. In order to guarantee the 
community easy access to high-quality, diverse programs, 
each United Way funded program is reviewed with careful 
consideration. With input from its volunteers and donors, 
United Way supports programs and initiatives that deliver the 
impact and results which the community needs. Their mission 
is to increase the organized capacity of people to care for one 
another. By helping people when they need it most - in the 
formative years of early childhood- we can prevent problems 
before they develop and significantly increase the number of 
successful adults in our community. That's why three of United 
Way's four strategic goals address the needs of children: 1) 
Children healthy and ready to learn when they start school; 2) 
Children succeeding in school; 3) Young people making 
positive choices, and 4) A safety net of services. 
This year's LVHHN campaign theme is "A Dollar Round-Up for 
OUR Community." This theme builds on the legend of the 
Lone Ranger and Tonto. This profound message embedded in 
the Lone Ranger Creed echoes our plea for your support. 
"I believe that to have a friend, a person must be one. That all 
people are created equal and that everyone has within themselves 
the power to make this a better world. Our Higher Power put the 
firewood there, but that every person must gather and light it 
themselves. In being prepared physically, mentally, and morally to 
fight when necessary for that which is right." 
Please fight for that which is right by supporting this year's 
campaign! 
All physicians and staff will be receiving a personalized pledge 
and designation form in the upcoming weeks. Please join 
Elliot J. Sussman, MD, David M. Caccese, MD, Robert J. 
Laskowski, MD, Mark C. Lester, MD, Brian A. Nester, DO, 
Donald L. Levick, MD, Theresa A. Ryan-Mitlyng, MD, John 
Jaffe, MD, Louis L. Liebhaber, and other organizational leaders 
through a pledge to this year's campaign. For more 
information, please refer to the United Way Intranet website on 
the LVHHN Intranet or contact a member of the campaign 
team: Linda Durishin (484-884-4867), Maureen Sawyer (484-
884-2304) or Donna Kulp (484-884-4860). 
The United Way is the way to a better Lehigh Valley! 
At its August 8 meeting, the Medical Executive 
Committee reviewed and approved the 
Withholding/Withdrawing Treatment Policy. A 
copy of the policy is attached for your 
information and review. 
Papers, Publications and Presentations 
Dennis B. Cornfield, MD, Section of Hematopathology, co-
authored a paper-- "Follicular Lymphoma Can Be 
Distinguished From Benign Follicular Hyperplasia by Flow 
Cytometry Using Simultaneous Staining of Cytoplasmic bcl-2 
and Cell Surface CD20" -- which was published in the August, 
2000 edition of the American Journal of Clinical Pathology. 
Gabriela Ghitulescu, MD, former Colon/Rectal Surgery 
resident, co-authored a chapter with lndru T. Khubchandani, 
MD, Division of Colon and Rectal Surgery, titled, "The 
Genetics of Colon and Rectal Cancer," which was included in a 
book published by Revinter Brazil in July 2000 -- New Trends 
in Coloproctology. This was a multi-author book with invited 
contribution by authors from around the world. 
Mark A. Gittleman, MD, Division of General Surgery, 
presented a Stereotactic Breast Biopsy Seminar at Gottlieb 
Memorial Hospital in Melrose Park, Ill., on July 8. 
Herbert C. Hoover, Jr., MD, Chairperson, Department of 
Surgery, co-authored the article, "Somatostatinoma of the 
ampulla of Vater in celiac sprue," which appeared in the 
July/August, 2000 issue of the Journal of Gastrointestinal 
Surgery. 
lndru T. Khubchandani, MD, Division of Colon and Rectal 
Surgery, was the Program Chairman at the XVIII Biennial 
Meeting of the International Society of University Colon and 
Rectal Surgeons held in Sao Paulo, Brazil, from July 23 to 27. 
Dr. Khubchandani serves as Director General of this society. 
Dr. Khubchandani participated in the Panel on Carcinoma of 
the Rectum and gave an oration titled, "New Trends in the 
Management of Inflammatory Bowel Disease," at the Conjoint 
Meeting of the Brazilian Society of Colon and Rectal Surgeons. 
Gary G. Nicholas, MD, Program Director, General Surgery 
Residency; Dona C. Hobart, MD, former General Surgery 
resident; James F. Reed Ill, Senior Scientist/Biostatistician, 
Department of Community Health and Health Studies; and 
Susan Nastasee, former surgical editor, co-authored the 
paper, "Carotid endarterectomy outcomes research: reduced 
resource utilization using a clinical protocol," which appeared 
in the August issue of Cardiovascular Surgery. 
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Robert D. Riether, MD, Director, Colon/Rectal Residency 
Program; Khawaja Azimuddin, MD, former Colon/Rectal 
Surgery resident; lndru T. Khubchandani, MD, Division of 
Colon and Rectal Surgery; Lester Rosen, MD, Associate 
Chief, Division of Colon and Rectal Surgery; and John J. 
Stasik, MD, Chief, Division of Colon and Rectal Surgery, co-
authored a paper-- "Transanal Endoscopic Microsurgery for 
Excision of Rectal Lesions: Technique and Initial Results"--
which was accepted for publication in a forthcoming issue of 
Surgical Laparoscopy, Endoscopy & Percutaneous 
Techniques. 
Michael C. Sinclair, MD, Acting Chief, Division of Cardia-
Thoracic Surgery; Martin LeBoutillier Ill, MD, Division of 
Cardio-Thoracic Surgery; William Gee, MD, Division of 
Vascular Surgery; Theodore Phillips, MD, Division of Cardia-
Thoracic Surgery, and Raymond L. Singer, MD, Division of 
Cardio-Thoracic Surgery, co-authored the paper, "Extra-
anatomic redo MIDCAB/OPCAB--an early experience," which 
appeared in the June, 2000 issue of Heart Surgery Forum. 
Upcoming Seminars, Conferences and 
Meetings 
Medical Grand Rounds 
Medical Grand Rounds will resume on Tuesday, September 5. 
Medical Grand Rounds are held every Tuesday beginning at 
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest 
& 1-78, and via videoconference in the First Floor Conference 
Room at Lehigh Valley Hospital-Muhlenberg, and in the Video 
Teleconference Room (formerly the Medical Staff Lounge) at 
17th & Chew. 
Topics to be discussed in September will include: 
~ September 5 - Selection of Appropriate Antibiotics for 
Critically Ill Patients 
~ September 12 - Remissive Therapies for Rheumatoid 
Disease: Present- Future 
~ September 19 - Up to Date: Access tot he Most Recent 
Clinical Literature 
~ September 26 - The Challenges of Developing Systems of 
Coordinated Care for Older Adults 
For more information, please contact Diane Biernacki in the 
Department of Medicine at (610) 402-5200. 
LVH Medical Staff Listing Available via Internttt 
A listing of members of the LVH Medical Staff is 
now available via the internet at the following 
website: http://www.lvh.com. At the top of the 
home page, click on "lvhhn.org," then, click on 
"Physicians Directory." You may then select a 
physician by last name or by specialty. This 
information is updated on a monthly basis. 
Who's New 
The Who's New section of Medical Staff Progress Notes 
contains an update of new appointments, address changes, 
status changes, etc. Please remember to update your 
directory and rolodexes with this information. 
Medical Staff 
Address Changes 
Frank J. Altomare, Jr., MD 
Altomare & Associates 
5930 Hamilton Blvd. 
Allentown, PA 18106-9654 
(610) 435-2001 
Fax: (610) 435-6948 
Bausch & Jones Eye Associates 
~ Andrew N. Bausch, MD 
~ David G. Jones, MD 
Plaza West 
1616 Allen Street 
Allentown, PA 18102-2012 
(610) 432-0201 
Fax: (610) 434-1210 
Frank DeFrank, MD 
(No longer with Bethlehem Steel Family Health Center) 
2246 High Road 
Cresco, PA 18326-9708 
Stephen P. Falatyn, MD 
Orthopedic Surgical Group 
701 Ostrum Street 
Suite 602 
Bethlehem, PA 18015-1153 
(610) 807-9400 
Fax: (610) 691-5533 
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Fred Laufer, MD 
4501 Crackersport Road 
Allentown, PA 18104-9326 
(61 0) 336-9000 
Fax: (610) 336-9424 
Lehigh Valley Internists 
~ David P. Carney, MD 
~ Glenn S. Kratzer, MD 
~ Judith A. McDonald, MD 
~ Daniel T. Mulcahy, DO 
~ John D. Nuschke, Jr., MD 
~ Timothy E. Steckel, MD 
798 Hausman Road 
Suite 220 
Allentown, PA 18104-9124 
(610) 530-2290 
Fax: (61 0) 530-2287 
(Effective 8/28/00) 
LVPG·Psychiatry 
~ Joseph L. Antonowicz, MD 
~ Yelena Yermak, MD 
~ Kenneth J. Zemanek, MD 
1251 S. Cedar Crest Blvd. 
Suite 202A 
Allentown, PA 18103-6214 
(610) 402-5766 
Fax: (610) 402-5763 
(Effective 8/28/00) 
Joseph T. Sembrot, MD 
(Retired from VA Clinic) 
1402 Cedarwood Road 
Allentown, PA 18104-2112 
(610) 395-4565 
Howard A. Silverman, MD 
798 Hausman Road 
Suite 270 
Allentown, PA 18104-9124 
(610) 871-0100 
Fax: (610) 871-0102 
(Effective 9/1/00) 
The 5th Edition of the Medical Staff Handbook 
has been published and is now available in Medical 
Staff Services and in the Medical Staff Lounge, 
both on the first floor of Lehigh Valley Hospital, 
Cedar Crest & I-78. 
New Practice Name and Address 
Wasserman, Redenbaugh, Margraf & Spikol, PC 
New Practice Name - Valley Neurology Consultants, PC 
~ John W. Margraf, MD 
~ James E. Redenbaugh, MD 
~ Lorraine J. Spikol, MD 
~ Ronald E. Wasserman, MD 
1210 S. Cedar Crest Blvd. 
Suite 1000 
Allentown, PA 18103-6208 
(610) 434-0107 
Fax: (610) 434-5337 
New Practice 
Geraldo A. Saavedra, MD 
(No longer with Sam Bub, MD, PC) 
Medical Associates of Monroe County 
239 E. Brown Street 
Suite C 
East Stroudsburg, PA 18301-3096 
(570) 421-3872 
Fax: (570) 421-0842 
Practice Disassociation 
Jenni Levy, MD 
(No longer with LVPG-Medicine) 
128 Fairhill Road 
Hatfield, PA 19440 
Pager Number Correction 
In the new 5th Edition of the Medical Staff Handbook, the pager 
number for D'nese M. Sokolowski, MD, was incorrect. Her 
correct pager number is 610·778·7754. 
Report from the Nominating Committee 
The following name has been submitted by the 
Nominating Committee for the position of 
President-elect: 
Alexander D. Rae-Grant, MD 
An election will be held at the General Medical Staff 
Meeting on September 11. Nominations will also be 
accepted from the floor. 





The Lehigh Valley Health Network has dedicated itself and its resources to the provision 
of high quality, compassionate and ethical medical care to patients, their families and the 
community at large. Lehigh Valley Health Network is dedicated to helping the people of 
our service area achieve and maintain optimum health status. As a charitable, not-for-
profit organization, we provide health services to our patients based on need, regardless 
of ability to pay. As a part of that care, this hospital recognizes that 
withholding/withdrawing medical treatment (including CPR) can be a part of a 
patient/family's wishes, consistent with the patient's self-determination, the duties of the 
health care professionals providing the care, and the mission of the hospital. 
The Policy recognizes the relief of suffering, the stabilization of disease processes and the 
curing of illness to be a spectrum of care which must be tailored to each patient's needs 
and possibilities. It espouses the ancient professional adage, 11 TO cure sometimes, to 
relieve often, to comfort always. 11 
Purpose: 
To provide the rationale and guidelines for withholding/withdrawing life-sustaining 
medical treatment(s) 
Presumptions: 
A. Patients may accept or refuse recommended medical care even when life-
threatening·conditions are present, whether or not they are tenninally ill. This is 
the principle of autonomy or self-determination which has been upheld by the 
courts and ethical scrutiny. 
B. Self-determination requires the patient with capacity (competent) to have 
adequate information which he/she can understand and accept or reject without 
coercion. Informed consent/refusal is a requirement of the legal and ethical 
systems for the person who has capacity (is competent). 
1 
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C. When a patient does not have the capacity to make decisions about medical 
treatment, it is appropriate for a person who has either legal standing (guardian or 
durable power of attorney) or a loving, caring familial relationship with the 
patient to make medical decisions regarding his/her treatment. This person is 
called a surrogate decision-mak-er and is a person (usually a family member) 
who knows and has a caring relationship with the patient. 
D. Professional health care clinicians have duties toward the patient which are part of 
the provider-patient relationship. The principle of beneficence or doing good for 
the patient must be balanced with the patient's wishes and decisions. Informing 
and convincing without coercion are part of that duty, trying to help the patient 
make decisions which are consistent with his/her values. 
E. WITHHOLDING AND WITHDRAWING MEDICAL TREATMENTS are 
equivalent acts from both a legal and ethical point of view. The conditions which 
make withholding medical treatment legitimate also justify withdrawing similar 
treatments. It is recognized that the two concepts in practice often feel different 
and may elicit different emotional responses in carrying out the decisions. 
F. When comfort care is needed in withholding and withdrawing situations, the 
principle of double effect is generally recognized and accepted. This principle 
states that actions may have two effects and one of these effects is unintended. 
These actions meant for comfort may hasten death but are not intended for that 
end and have no acceptable alternatives. Pain and dyspnea control with adequate 
analgesics, usually narcotics, become part of the treatment but may also hasten 
death, the double effect. 
G. Food and/or fluid given by tube or intravenous means are considered medical 
treatment and may be withheld/withdrawn under the same ethical pririciples as 
other medical treatments such as CP~ mechanical ventilation, dialysis, etc. 
Every effort should be made to continue nourishment by mouth whenever 
feasible. (Refer to Attachment A) 
H. Withholding a specific treatment does not indicate that other care deemed 
necessary for the patient will be diminished or not provided. The patient and 
family should never be abandoned in fact or perception. Comfort measures and 
compassionate caring must be continued and may need to be intensified when the 
decision to withhold/withdraw has been made. Under no circumstances should 
caring be withheld/withdrawn. 
2 
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I. The hospital recognizes the difficulties of defining futility and futile medical 
treatment but believes that there are situations where continuing previously 
recommended aggressive therapy is medically useless and is counter to the 
patient's best interestS (and perhaps his/her wishes) as well as the best interests of 
the family; friends and society. A process for working through these situations is 
provided in Attachment B. 
J. Thorough communications are required among the persons involved with the care 
of the patient and with the patient and the family (if permitted by the patient). 
The patient with decision-making capacity does not require a surrogate and should 
make her/his own decisions about medical treatment and evaluation. If the 
patient does not have the capacity to make autonomous decisions, information to 
make informed consent/refusal needs to be provided to the appropriate surrogate 
decision-maker. Patient, compassionate, understandable communication with the 
patient or surrogate are required before and after decisions to pursue or 
withhold/withdraw therapy. Meaningful communication ·between the patient and 
the patient's family along with the multi disciplinary health care team and also 
among the health care team should continue throughout the patient's illness and 
hospitalization. 
K. Time-limited trials of therapy are possible because withholding and withdrawing 
therapy are ethically and legally permissible. These trials permit time for 
clarification of medical uncertainties by testing, observation and progression. 
Because of continued reasonable uncertainty or changes in conditions, time-
. limited trials may be extended by mutual agreement among the health care team 
and patient/surrogate but should not be used as a mechanism to avoid appropriate 
but difficult decisions or to ignore the wishes of the patient/surrogate. 
L. This policy purposefully does not deal with health care costs and allocation of 
scarce resources since these are issues which must be determined on a "macro" or 
societal level and apply to all patients if they are to be equitable and fair. This 
policy speaks to issues between individual patients and their surrogate(s) and the 
health care team caring for that patient. This does not preclude the consideration 
of medical futility as addressed in Section I and Attachment B. 
M. In Pennsylvania there is living will legislation which, if executed and signed by a 
patient, may obligate the provider(s) to withhold/withdraw therapy which is life-
sustaining if the patient is in an irreversible coma or has a terminal illness. 
Conditions and prognoses which fall outside these parameters are not legally 
binding, but, ethically, the living will must be i,nterpreted to attempt to understand 
patients' wishes for a particular condition and prognosis applying to them at that 
time. In Pennsylvania special requirements apply to pregnant women in the living 
will legislation. (Pennsylvania Senate Bill #3). 
3 
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N. A durable power of attorney for health care is a person designated in writing by 
the patient (when mentally competent) to speak for the incapacitated patient in 
medical decision making. The durable power does not become effective until the 
patient is deemed incapacitated and cannot make decisions for her/himself. If the 
patient should regain capacity the decision-mak.big authority reverts back to the 
patient. If there is a durable power of attorney named, that person becomes the 
designated surrogate decision-maker. 
0. · CliniCal Circumstances: 
1. The patient with capacity (competent) should make decisions about his/her 
own treatments. The patient should participate in appropriate discussions 
with family and clinicians to assess information about diagnosis, prognosis 
and benefits and burdens, allowing the patient to make an informed . · 
decision. Persuasion, not coercion, is legitimate on the part of clinicians. 
The family does not have the ethical or legal right to make decisions for a 
competent patient without that patient's consent or formal transfer of 
decision-making authority. 
2. Patients who lack capacity for decision-making can be represented by a 
legitimate surrogate decision-maker who tries to use substituted 
judgment to extend the patient's wishes. The surrogate should interpret 
the information and make decisions as they believe the patient would if 
he/she could make the decision autonomously. If the surrogate does not 
have enough.inform.ation about the patient's previous wishes or thoughts 
about death and dying, suffering, pain, quality of life, etc., to make a 
substituted judgment decision, the principle of best interest can be used. 
This weighs the benefits and burdens of the active pursuit of medical care 
and assesses whether or not the benefits outweigh the burdens. If so, 
therapy should be continued, if not, therapy can be withheld/withdrawn. 
3. Persons who never had capacity to be autonomous (children, never 
competent adults, etc.), present different problems in decision making 
since autonomy has never been achieved. Therefore decisions must be 
made using the principles of beneficence and non-maleficence. In these 
cases surrogates must be designated for the patients and these surrogates 
should make decisions in the best interest of the patients. It may be 
necessary to ask the courts to appoint a guardian who will act as a 




4. A previously autonomous person who is now incapacitated and who has 
no known relatives or family or other legitimate surrogate, presents a 
difficult set of problems for the health care providers. In most cases the 
health care team in consultation with the Ethics Committee and Legal 
Services can reach a consensus about an appropriate course of action. If 
the issue is controversial with divergent opinions, a judge may be asked to 
intervene and appoint a guardian. 
ll. Scope 
Adult patients with capacity to make health care decisions or appropriate surrogate(s). 
Ill. Definitions 
Types of Treatments: 
Examples of life-sustaining medical treatment include, but are not limited to, the 
following: · 
A. Cardiopulmonary resuscitation 
B. Mechanical Ventilation with intubation 
C. No Non-Invasive ventilation for any reason (Bi-P AP) 
D. Dialysis 
E. Artificial hydration and nutrition 
F. Antibiotic therapy and other life-sustaining medications 
G. Achninistration of blood and blood products 
H. Surgery 
IV. Procedure 
A. Decisions to withhold or withdraw medical therapy should be a result of continual 
interchange of information and ideas between the health care team and the 
patient/surrogate. 
B. Once the decision has been made to limit medical therapy, an order must 
be written by the attending physician defining the limits. 
C. A progress note should reflect the thinking and process used to arrive at the 
decision to limit therapy. 
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D; When the decision is made to withhold therapy, the Withholding of Therapy 
Order Sheet must be completed as well as an order to this effect on the blue 
order sheet. 
E. The Withholding·OfTherapy Order Sheet will be placed inside the front cover of 
the chart, (the first document in the chart). 
F. When a Withholding Order is stopped, "VOID" will be written across the care 
. order check Sheet and it will be moved to the order sheet section of the chart. The 
order must be written on the usual order sheet as well. If the Withholding Order is 
later re-instated, a new form must be completed. 
G. Whenever a patient with a Withholding·Order leaves a patient care unit, the 
receiving department should be contacted by phone to alert them about the 
patient's withholding status, e.g. going to x-ray for chest file, etc., or patient for 
therapy. 
H. It is the responsibility ofthe receiving department to clarify the order, chart or 
phone message if not clearly understood by them. 
I. Canceling a Withholding of Therapy Order requires discussion and 
documentation similar to that required to write a Withholding order. The 
communication of the change must be transmitted to all who need to !mow. 
J. If a patient with a Withholding of Therapy Order has a procedure (test, therapy, 
etc.) which has some risk of causing a cardiac and/or respiratory arrest, 
clarification by the patient or appropriate surrogate regarding resuscitation is 
required. This should be obtained by the attending physician and affirmed by the 
physician performing the procedure as well as the anesthesiologist. This should 
be documented in the record. 
K. If conflict arises concerning the decision a team/family conference should be held 
to attempt to clarify the issues and develop consensus. 
L. If the team/family conference along with input from other sources does not 
resolve the conflict, an Ethics Consultation should be requested. (Refer to, Ethics 




Attachment A - Artificial Nutrition and Hydration 
Attachment B - Futile* Care 
Attachment C - Withholding/Withdrawing Treatment Order Sheet 
VI. Distribution 
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President and Chief Executive Officer 
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X. Disclaimer Statement 
This policy and the implementing procedures are intended to provide a description of 
recommended courses of action to comply with statutory or regulatory requirements 
and/or operational standards. It is recOgnized that there may be specific circumstances, 
not contemplated by laws or regulatory requirements, that make compliance 
inappropriate. For advice in these circumstances, consult with the Department of Risk 
Management/Legal Services. 
XI. Revision Dates 
Origination: August 1995 




ARTXFICIAL NUTRITION AND ~RATION 
1. Ethically and legally, artificial nutrition and hydration is 
no different than other forms of life-sustaining medical 
treatment. In appropriate cases, discontinuing certain 
medical treatments is accepted despite the fact that death 
is as certain as with withholding medical nutrition and 
hydration. Withholding dialysis in a patient without kidney 
function is an example. 
2. In many instances, the burden of administering artificial 
nutrition and hydration outweighs potential benefits. Such 
burdens include: risk of infection such as pneumonia and 
sinusitis secondary to nasogastric tubes, discomfort 
secondary to nasogastric tube, and risks of hemorrhage, 
infection, fluid overload, and thrombosis associated with 
central venous parenteral alimentation. 
3. Potentially beneficial effects of dehydration in the 
terminal patient include decrease in G.I. fluid resulting in 
less vomiting, reduction in pulmonary secretions with less 
coughing and drowning sensation, and reduction in edema 
around tumors leading to decreased pain. 
4. Studies have addressed the comfort of terminally ill 
patients from whom artificial nutrition and hydration was 
withheld. 
Physiologic adaptation to fasting leads to lipolysis and 
increased ketone production which decreases the feeling of 
hunger. 
Most patients studied never expe~ienced any hunger. When 
present, symptoms of hunger, thirst and dry mouth were 
alleviated with small amounts of food and fluid given orally 
or by the application of ice chips and lubrication of the 
lips. 
Although it has been felt that the major distressing symptom 
of dehydration is dry mouth, Hospice experts report that 
dying patients who are dehydrated are rarely thirsty. 
5. The provision of nutrition and hydration has been equated 
with care and compassion. It is, nevertheless, possible to 
provide a high level of compassion and dignity to the dying 
patient without artificial nutrition. 
References: 
l.. McCann, et al. Comfort Care of Terminally Ill Patients - The Appropriate 
Use of Nutrition and Hydration. JAMA,l.994:276(l.6) ;l.263-l.266. 
2. Andrews, ,MR and Levr~, AM. Dehydration in the Terminal Patient: 





Purpose: To provide guidelines when the attending physician 
believes that further care (other than comfort care) is 
futile, but the patient or the patient's family insist 
on continuing the effort. This statement does not apply 
to rationing medical care and should not be used for 
this purpose. 
1 The attending physician should take enough time to carefully 
explain to the aware patient and to the family the nature of 
the, ailment, the options and the prognosis. The physician 
should explain that abandoning the. treatment does not mean 
abandoning the patient in terms of comfort, dignity and 
psychological support. 
2 The attending physician should provide the names of 
appropriate consultants to provide an independent opinion 
concerning the futility of the situation. 
3 The assistance of the nurses, chaplain, patient 
representative and social services should be offered to the 
patient's family. A joint conference with the doctor is 
desirable. 
4 An Ethics Consultation may be called to consider the matter 
and offer advice and counsel to the physician, family and 
healthcare team. {Refer to AD#l600.06, Ethics Consultation 
Process) 
5 Adequate time should be given for the patient and family to 
consider this information. 
6 If all of these steps are taken and the family remains 
unconvinced, neither the doctor nor the hospital are 
required to provide care that is not medically indicated, 
and the family may seek a substitute physician (if one can 
be found) and another hospital (if available). The Lehigh 
Valley Hospital will assist the family in their efforts to 
find those substitutes. 
7 If the patient can no longer benefit from an acute hospital 
stay and the patient or family insists on staying, the 
mechanism for personal payment can be invoked. 
FUTILE* CARE - Any clinical circumstance in which the doctor and 
his/her consultants, consistent with the available medical 
literature, conclude that further treatment (except comfort care) 
cannot, within reasonable possibility, cure, improve or restore a 
quality of life that would be satisfactory to the patient. 
References: Rivin, AU. Are Futile-Care Policies The AnSWer? Hospitals and 
Health Networks,l994:February 20. 
LEHIGH VALLEY HOSPITAL 
ALLENTOWN, PA 
LEHIGH VALLEY HOSPITAL· MUHLENBERG 
BETHLEHEM, PA IIIII 
WITHHOLDING OF THERAPY 
ORDER SHEET 
(Also write •see 'Mthho/ding Order Sheer on the regular order sheet). 
WITHHOLDING OF THERAPY ORDER 
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The patient and/or surrogate request the withholding of medical therapy as indicated below: (Currently active orders will continue until 
altered by further orders.) 
~~n ,- 0 No CPR-cardiopulmonary resuscitation, code blue, ACLS Protocol 
0 No Electrical defibrillation 
0 No Mechanical ventilation with intubation for any reason 
0 No Non-Invasive mechanical ventilation for any reason (bi-pap) 
0 No Vasopressorslionotropic agents 
0 No Antiarrhythmics 
0 No Dialysis · 
0 No Hyperalimentation 
0 No Tube feedings 
0 No Blood or blood products 
0 No Antibiotics 
0 No Electrolytes or acid/base corrective measures 
0 No Treatment for low urine output 
0 No Transfer to ICU or monitored bed 
The above list is not meant to be all-inclusive. If the patient's/surrogate's wishes cannot be expressed through this list, clarify and 
explain those wishes below. 
I have discussed this with the patient/patient surrogate ---------------------,-----
who understands the order. NAME 






DISCONTINUE THE ABOVE ORDER(S) IMMEDIATELY. 
(See next order sheet for specific orders) 
PRINTED NAME 
{ALSO, WRITE ORDER TO DISCONTINUE WITHHOLDING STATUS ON REGULAR ORDER SHEET) 
SIDE 1 OF 2 
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1 . The Withholding Order Sheet will be placed inside the front cover of the chart, (the first 
document in the chart). 
2. When a no CPR order is stopped, 'VOID" will be written across the order check sheet and it 
will be moved to the order sheet section of the chart. The order must be written on the usual 
order sheet, as well. If the no CPR is later reinstated, a new form must be completed. 
3. Whenever a patient with a no CPR order leaves a patient care unit, the receiving department . 
should be contacted. by phone to alert them about the patient's resuscitation status, e.g., 
going to X-ray for chest film, etc., or patient for therapy. This should be done by the primary 
nurse or his/her designee. 
4. · It is the responsibility of the receiving department to clarify the order if the chart or phone 
message is not clearly understood by them. 
5. Cancelling a no CPR order requires discussion and documentation similar to that required to 
write a no CPR order. The communication of the change must be tran~mitted to all who 
need to know. 
6. If a patient with an active no CPR order has a procedure (test, therapy, etc.) which has some 
risk of causing a cardiac and/or respiratory arrest, clarification by the patient or appropriate 
s~rrogate regarding resuscitation is required. This should be obtained by the attending 
physician and affirmed by the physician performing the procedure. 
MRD-36 Rev. 6/00 SIDE 2 OF 2 
LEH!f!HVAILEY Page23 
HOSPITAL 
THERAPEUTICS AT A GLANCE 
The following actions were taken at the July/August 2000 Therapeutics Committee Meeting- James Sianis, Pharm.D., Christopher Moore, 
PharmD., Joseph Ottinger, R.Ph., MS, MBA 
ADR Reporting 
Suspected ADR reports for the second quarter of 
2000 demonstrated a similar quantity of notations 
and 'severity' to those of the previous quarter. 
Anticoagulation therapies continue to comprise the 
largest measure of reports considered "Severe" . 
Comparative incident/volume activity levels (e.g., 
reports per 10,000 doses administered and reports 
per 1,000 adjusted admissions) were almost 
identical to the previous quarters data. One death 
was recorded in the 61 reports. Drug therapy was 
not considered to be a primary contributing factor. 
An additional report of bleeding associated with 
use of enoxaparin in a patient with a calculated 
estimated creatinine clearance of < 30 ml/min was 
noted. This drug is renally excreted. Physicians 
are reminded that use of enoxaparin in patients with 
an estimated creatinine clearance of less than 30 
ml/min. is not widely studied. These patients were 
excluded from all the major published studies to 
date. Therefore, dosing alterations are not well 
described. In addition, patients would require 
laboratory monitoring via use of ant-factor Xa 
heparin activity levels. Pharmacy "notes" restating 
this information are placed on appropriate patient 
charts identified through a daily monitoring process. 
All health-care personnel are encouraged to report 
suspected adverse drug reactions. Copies of the 
Suspected Adverse Drug Reaction Documentation 
Form are available in all patient care areas. 
Complete as many portions of the form as you can 
or at least notify the Pharmacy staff of your 
observations. A pharmacist will review the case 
and complete/initiate the form as necessary. ALL 
REPORTS are confidential and they are 
summarized and presented to the Therapeutics 
committee. Cause-effect analysis and trending 
considerations are reviewed in this process. Patient 
allergy data are updated in accordance with the level 
of suspicion based on the Naranjo scale and 
patient's may receive "ID" cards describing the 
nature of the reactions and the presumed associated 
cause. This information card can be carried by the 
patient and presented in future health-care 
interventions requiring drug treatments. · 
Following are the particulars for this quarter 
Second quarter 
Reports per 10,000 doses 0.63 
Reports per 1,000 admissions 5.53 
Second Quarter Data 




































































Table 4: Adverse Reaction Severity 





Most Common Agent 
Contrast dye- 8 
heparin w/others- 6 












Drug Formulary Issues 
The Therapeutics Committee at its August meeting 
approved the addition of the Class III 
antiarrhythmic, dofetilide (Tikosyn). Dofetilide is 
indicated for the conversion of atrial fibrillation 
and atrial flutter to normal sinus rhythm. It has 
not been shown to be effective in patients with 
paroxysmal atrial fibrillation. Dofetilide is also 
indicated for the maintenance of normal sinus 
rhythm in patients with atrial fibrillation and atrial 
flutter of greater than 1 week duration who have 
been converted to normal sinus rhythm. Because 
dofetilide is associated with life-threatening 
ventricular arrhythmias, its use should be reserved 
for patients in whom atrial fibrillation or atrial 
flutter is highly symptomatic. 
Therapy with dofetilide must be initiated or re-
initiated only in patients placed for a minimum of 
3 days in a facility that can provide calculations of 
creatinine clearance, continuous 
electrocardiographic monitoring, and cardiac 
resuscitation in order to minimize the risk of 
induced ventricular arrhythmias. In addition, only 
those physicians certified to prescribe dofetilide 
may initiate (re-initiate) therapy. 
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Initiation of therapy will require use of a 
preprinted order form that provides all the 
mandated monitoring and prescribing information 
necessary to facilitate therapy. Patient education 
materials will also be given to the patient that 
highlight the need for screening for drug-drug 
interactions prior to the initiation of 'other' 
therapies .. Once the patient leaves the Hospital, 
drug must be obtained from Stadtlander's 
Pharmacy (the only licensed Pharmacy supplier) 
via mail order. The patient does receive a 7 day 
supply of medicine upon discharge from the 
hospital that provides a 'bridge' until the 
Stadtlander's materials arrive. 
Patients re-admitted to the hospital may have 
therapy continued by the attending service, unless 
therapy is discontinued for longer than 24 hours 
(Must be reinitiated via protocol). These patients 
will have a Pharmacy information sheet placed on 
the chart elaborating drug interactions and other 
particulars. (See attached) 
Also reviewed and approved to the formulary was 
the short-acting, non-depolarizing neuromuscular 
blocker rapacuronium (Raplon). Rapacuronium is a 
rapid onset neuromuscular blocker with a short 
duration of action. It may be possible to use 
rapacuronium as a replacement for succinylcholine 
and other neuromuscular blockers, in selected 
situations. (See contraindications) 
An additional niche for rapacuronium use has been 
identified in 'short' procedure cases, where it would 
be utilized to replace the 'longer half-life' agents 
currently utilized facilitating a faster recovery. The 
Anesthesia department has developed usage 
guidelines for this agent, which are described below. 
Cases where an agent with the duration of 
action less than 30 minutes are needed. 
Cases in which succinylcholine is 
contraindicated and rocuronium is 
inappropriate. 
Pediatricicas~s greater than 1 month of age 
where rocuronium is contraindicated. 
When cases exceed a 30 minute time limit, 
use of a second muscle relaxant is 
indicated. 
Current Contraindications for the use of 
Succinylcholine 
Hypersensitivity to succinylcholine. 
Patients with a personal or family history of 
malignant hyperthermia or a history of skeletal 
muscle myopathy. 
Patients in the acute phase of injury with major 
burns, multiple trauma, extensive denervation of 
skeletal muscle or upper motor neuron injury. 
Acute narrow angle glaucoma. 
Penetrating eye injury. 
Also has 'black box' warning for risk of cardiac 
arrest from hyperkalemic rhambdomyolysis in 
otherwise healthy pediatric patients. 
Heparin Order sheet 
A revised intravenous heparin order sheet has been 
developed to facilitate use of this important agent. 
The order sheet will contain the more widely used 
dosing schemes, but physicians will be able to 
describe individually tailored regimens, if 
necessary. The order format was approved, but 
the form will be 'held', as the laboratory will 
shortly be converting to a more sensitive reagent 
to measure aPTT. Notification of the new 
therapeutic range will be forthcoming in a future 
edition of this newsletter. 
Vioxx (Rofecoxib) Approved for 
Formulary 
After much anticipation, Therapeutics committee 
voted to add rofecoxib (Vioxx) to the L VH 
formulary. This agent selectively inhibits the cox-
2 enzyme and prevents the synthesis of 
inflammatory prostaglandins. Rofecoxib is 
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indicated for the management of the pain 
associated with osteoarthritis as well as acute pain. 
The advantage of agents such as rofecoxib is the 
ability to take advantage of the properties of an 
NSAID, without the undesirable side effects of 
traditional NSAIDS. The committee also voted to 
allow the pharmacy to automatically substitute 
rofecoxib for celecoxib(Celebrex) when ordered by 
the residents and medical staff. The following 
scheme will be used for this substitution: 
Celecoxib up to 200 mg per day- Rofecoxib 12.5 
mg PO qd 




Dofetilide Infor\naqon Sheet 
Dear Doctor, 
This patient has been prescribed dofetilide (Tikosyn). Please, be aware that these patients should be closely 
monitored for changes in renal function, prolonged QT interval and electrolyte (potassium) disturbances. In 
addition, this agent is contraindicated with certain drugs and should be administered with caution when given 
with other agents that prolong the QT interval. Below is a list of agents that have been identified as 
potentially problematic. 
Additionally, patients NOT receiving therapy for longer than 24 hours should be re-titrated on dofetilide 
using the FDA mandated dosing schedule. This will require that a Physician certified via the FDA mandated 
program to initiate (reinitiate) therapy be contacted. Pharmacy can provide a list of those individuals whose 
credentials are on file. 
Tikosyn (dofetilide) can NEVER be co-administered with verapamil (lsoptin; Calan), ketoconazole (Nizoral), 
cimetidine (Tagamet), trimethoprim (Trimpex, Bactrim, Septra), prochlorperazine (Compazine), or 
megesterol (Megace). 
In addition, the following list of drugs may prolong the QT interval and precipitate irregular heart beats. 






















In addition to these drugs, try to avoid low blood potassium and probably low magnesium as well. Low 




News from the Library 
OVID Training. 
The Library has completely converted to OVID's on-line 
MEDLINE system. This Web-based system is updated daily by 
Ovid. Call Barbara Jobst in the Health Sciences Library at 610-
402-8408 to schedule a one-on-one training session. 
NEW TELEPHONE/FAX NUMBERS FOR 
LEIDGH VALLEY HOSPITAL-
MUHLENBERG LmRARY. 
Please use the following telephone nwnber when requesting 
information from the L VII-Muhlenberg Library: 610-401-8410. 
For faxing requests to the L VII-Muhlenberg campus Library, the 
fax nwnber is 610-402-8409. 
The new nwnbers enable the Library staff to consolidate services 
in order to better serve our customers and control costs. 
IN THE LITERATURE. 
This is a reminder about the recent debut of our new, :free table-
of-contents service, "IN THE LITERATURE." You need not 
visit the library to keep abreast of the latest medical 
information. From your PC, you can peruse the table of contents 
of such widely-read journals as" JAMA," "New England Journal 
of Medicine," "Lancet," "Obstetrics and Gynecology," 
"Journal of Trauma," "Archives of Surgery," "American 
Journal of Medicine," "Critical Care Medicine," "American 
Journal of Public Health," "Pediatrics," "Annals of Internal 
Medicine," "American Heart Journal, and "Nature," etc. This 
table-of-contents service allows you to request photocopies of 
articles published in these journals. Information about this 
service, a complete list of journal titles, and instructions 
explaining how to request an article can be found by visiting the 
L VHHN Intranet Click on the mow in the "•Resources•" box 
to display the drop-down menu. Select "Clinical." On the next 
screen, captioned "Clinical Links & Resources," click on "Table 
of Contents Service." If you need assistance in obtaining 
information about "IN THE LITERATURE," call61 0-402-
2263 or 610-402-841 0 
1 
Computer-Based Training CCBD: 
Computer Based Training (CBT) programs are available for 
L VHHN staff. Topics covered by the CBT programs include: 
Access 2.0 Power-Point 4.0 
Windows NT 4 Word 97 
Excel 97 Access 97 
PowerPoint 97 Lotus 1-2-3 Millenniwn 
WordPerfect 8 E-mail GUI 
PHAMIS Last Word Inquiry Only commands 
CBT programs replace the instructor-led classes previously held 
at Lehigh Valley Hospital. A proctor will be in the room with 
the learner while he/she takes the CBT, but the learner will 
control the pace and objectives of the learning. 
Computer Based Training takes place in Suite 401 of the John 
& Dorothy Morgan Cancer Center (the computer training 
room) and in the Muhlenberg Hoapital Center computer 
trainln& room (off the front lobby). The schedule of upcoming 
dates is as follows: 
CBT sessions for JDMCC, suite 40 I are as follows: 
September 12, Sam - Noon 
Sessiogs at MUC, I.S. Training room are as follows: 
September 26, Sam - Noon 
Twelve slots are available for each session. 
To register, please contact Suzanne Rice via e-mail or at 484-
SS4-2560 with the following: 
date of session 
second date choice 
department 
phone nwnber 
You will receive an e-mail confirming your choice within two 
business days. If you have any questions, please contact Craig 
Koller at 610-402-1427 or through e-mail. 
Any questions, concern& or comments on articles from CEDS, please 
contact Bonnie Schoeneberger 610-402-1210 
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